New Jersey Headlines

Creative Biolabs Provides Various Recombinant Antibodies for Cancer Research

Creative Biolabs Provides Various Recombinant Antibodies for Cancer Research

March 20
17:12 2019

New York, March 20, 2019 Creative Biolabs, an antibody company with years of experience, now provides a comprehensive list of recombinant antibodies for the cancer research.

 

Cancer cells divide relentlessly to form solid tumors or flood the blood with abnormal cells. Besides the uncontrolled cell division, cancer cells also locally invade surrounding normal tissues and even transfer to other parts of the body via the internal circulatory system or lymphatic system. In recent years, cancer antibodies have come to the forefront in the cancer treatment fields because the diversity of antigens and antibody molecular structures provides a rich space for the development of tumor antibody drugs and their targeting ability makes possible to effectively kill cancer cells without damaging normal tissues.

 

In Creative Biolabs, a broad selection of research antibodies is available to accelerate the research of autophagy, metastasis, proliferative signaling, metabolism, and any other cancer-related research.

 

The gene of MUC16 antibody encodes a protein that is a member of the mucin family. Mucins are high molecular weight, O-glycosylated proteins on the apical surfaces of the epithelia to form a protective mucous barrier. The encoded protein is a membrane-tethered mucin that contains an extracellular domain at its amino terminus, a large tandem repeat domain, and a transmembrane domain with a short cytoplasmic domain. MUC16 antibodies are thought to play a role in forming a barrier, protecting epithelial cells from pathogens, which can be used as a marker for different cancers with higher expression levels associated with poorer outcomes.

 

 

Cadherins are calcium dependent cell adhesion proteins, which preferentially interact with themselves in a homophilic manner in connecting cells, thus contributing to the sorting of heterogeneous cell types. As a protein encoding gene, cadherin can be highly expressed in brain, cerebellum, and kidney. The related diseases of CDH6 include Renal Cell Carcinoma, Nonpapillary and its related pathways are Ectoderm Differentiation and ERK Signaling. Meanwhile, cadherin antibody can be applied to IHC-P, Flow Cyt, WB, ELISA.

 

“Our professional scientists can utilize advanced antibody research tools, professional technical support, and rapid global delivery to ensure quality for scientific research workers and customers in the industry. And based on years of experience, we are confident to guarantee clients high-affinity antibody products and a fast turnaround time.” Said the manager in Creative Biolabs.

 

More detailed information on various antibodies can be found on https://www.antibody-creativebiolabs.com.

 

About Creative Biolabs

Since 2004, Creative Biolabs has been dedicated to providing high-quality services to the academic and life sciences worldwide. In the past decade, Creative Biolabs become the leader in the discovery and manufacture of recombinant antibodies. A custom-service-centered business model is crucial for optimizing the drug development process, leveraging accessible resources, and gathering a team from various backgrounds to conduct drug discovery projects in the future. As the preferred supplier for global customers, scientists in Creative Biolabs are confident to provide customers with first-class services covering a full range of applications.

 

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-619-7922
Address:45-1 Ramsey Road
City: Shirley
State: New York
Country: United States
Website: https://www.antibody-creativebiolabs.com

Categories